Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency

Recruiting

Phase 3

GC5107Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency

Sponsor:

Green Cross Corporation

Code:

NCT04565015

Conditions

Primary Immune Deficiency

Eligibility Criteria

Sex: All

Age: 2 - 16

Healthy Volunteers: Not accepted

Interventions

GC5107

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Green Cross Corporation on 2023-05-17.